Cost-Effectiveness Analysis Expands its Reach Worldwide Academic Article uri icon


  • Economic evaluations such as cost-effectiveness analysis (CEA) have been used in many developed countries and health technology assessment (HTA) agencies to inform coverage and reimbursement decisions. Cost-utility analysis (CUA), a specific form of CEA, presenting a cost per quality-adjusted life-year (QALY) gained ratio is a commonly used form of economic evaluation in Western countries and has been recommended as a standard for comparisons across studies. Indeed, HTA guidelines in many countries prefer the submission and use of a CUA for technologies that are candidates for coverage and reimbursement [1]. Recent reviews suggest that the number of published CUAs has increased substantially in recent years. For example, the number of CUAs published worldwide has risen from 34 per year during the 1990s to 212 per year during the 2000s …

publication date

  • January 1, 2016